Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2019

Dec 12, 2019

34519_dirs_2019-12-12_f0058359-c2f0-455b-96c7-07dc2baafaa1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2019-12-09

Reporting Person: Brockmann Bobbi Jo (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-09 Common Stock, par value $0.10 per share A 1200.0000 $3.9900 Acquired 2255.0000 Direct
2019-12-09 Common Stock, par value $0.10 per share A 1524.0000 $3.6500 Acquired 3779.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-12-09 Incentive Stock Options (Right to buy) $3.9900 D 3800.0000 Disposed 2020-02-08 Common Stock (3800.0000) Direct
2019-12-11 Incentive Stock Options (Right to buy) $5.1750 A 10000.0000 Acquired 2029-12-11 Common Stock (10000.0000) Direct
2019-12-09 Incentive Stock Options (Right to buy) $3.6500 D 3476.0000 Disposed 2020-01-04 Common Stock (3476.0000) Direct